Sermo docs favor McCain's healthcare plan

Share this article:

Forty-four percent of Sermo physicians polled found Senator McCain's healthcare plan to be “beneficial to the country,” compared with 30% that said Senator Obama's is beneficial.

Additionally, 51% said Obama's plan is not beneficial for the country, versus 31% who said McCain's plan is not beneficial.

Sermo's polling was conducted following a Q&A with both candidates – McCain and Obama were asked to respond to five questions each. The questions posed to both candidates were proposed and voted on by Sermo physicians. 

After reviewing the answers from each camp, 30% of the polled physicians said the candidates' answers would change their vote from the candidate they'd previously supported. Twenty-three percent of those who read Obama's answers said they were influenced toward McCain, while 10% of the respondents said McCain's answers had swayed them toward Obama.

The polling closed on Friday, October 31, according to a Sermo spokesperson. Sermo is the largest physician-only online community, with approximately 90,000 US physician members. A ballpark number of physicians that participated in the poll weren't immediately available, although the spokesperson said it was “in the thousands.”

Share this article:

Email Newsletters

More in News

Sanofi expands Gaucher disease portfolio

Sanofi expands Gaucher disease portfolio

The oral medication Cerdelga joins Cerezyme in its Fabry disease arsenal. Sanofi expects the drug will be priced "on par" with Cerezyme, which goes for around $300,000 a year in ...

Amicus seeks to upset Fabry market

Amicus seeks to upset Fabry market

Phase-III tests indicate patients may be able to switch from injectable enzyme-replacement therapies, like Fabrazyme, to the firm's oral drug.

Five things for pharma marketers to know: Wednesday, August 20

Five things for pharma marketers to know: Wednesday, ...

Novartis explores the virtual care space, a court has dismissed a lawsuit against IPAB, Doctors Without Borders calls the Ebola outbreak "a complete disaster" and Pfizer becomes the first pharma ...